Ra Pharmaceuticals Inc

What indicators would you like to setup a trade for?

Candlestick Daily volume index Bar reversal Edit

Trade setup

Position Order Entry Exit Stop Loss Risk Return Expectancy
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

Company

Indicator

Code Company Date Close Change Indicator Value Signal

Trading Performance

Average Directional Index

Score

0.7

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 6 96.2 0.50% 1.00% 71.6% -4.6% 201.1%
SHORT 5 28.2 0.20% 0.25% 28.6% -13.4% -25.0%

Summary

Technical Analysis

Ra Pharmaceuticals Inc (RARX)


Indicator:

AVG DIRECTIONAL INDEX


Last Signal:

WEAK TREND


Trading: HOLD @ $46.58
Signal Strength: MEDIUM
Recommendation:

Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. This indicator has been constructed to highlight the existence of a trend for an assocaited timeframe. Trend determining indicators can be used in short, medium or long term timeframes & determines if the stock is trending or ranging. Once the trend status is quantified, this can then be coupled to additional indicators to add a significant advantage to the trading strategy.


Ra Pharmaceuticals Inc (NASDAQ:RARX) has confirmed a weak trend is presentRa Pharmaceuticals Inc has an ATR(14) of 0.313, a DX of 0.03 & an ADX(14) of 22.21



The Average Directional Index (ADX) Minus Directional Indicator (-DI) and Plus Directional Indicator (+DI) represent a group of directional movement indicators that form a trading system developed by Welles Wilder.

Calculation: Average Directional Movement Index (ADX):
Trend Strength ;
1) 0-25 = Absent or Weak Trend;
2) 25-50 = Strong Trend;
3) 50-75 = Very Strong Trend;
4) 75-100 Extremely Strong Trend;


PROFILE: Ra Pharmaceuticals Inc (RARX)


Stock Exchange: NASDAQ
Company: Ra Pharmaceuticals Inc
Ticker Codes: | RARX | NASDAQ:RARX |

About Ra Pharmaceuticals Inc (NASDAQ:RARX):

Ra Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of diseases caused by excessive or uncontrolled activation of the complement system in the United States. The company's peptide chemistry platform enables the production of synthetic macrocyclic peptides that combine the diversity and specificity of antibodies with the pharmacological properties of small molecules. Its lead product candidate is RA101495, an injection into the tissue under the skin that has completed Phase II clinical trial for the treatment of paroxysmal nocturnal hemoglobinuria (PNH); and is in Phase II clinical trial for treating patients with generalized myasthenia gravis (gMG), as well as in Phase 1b clinical trial for treating atypical hemolytic uremic syndrome (aHUS) and lupus nephritis (LN). The company's preclinical testing products include Factor D inhibition for orphan renal and dense deposit diseases, and C3 glomerulonephritis; Oral C5 inhibitor for PNH, gMG, aHUS, LN, and central nervous system (CNS) diseases; and other complement inhibitors for autoimmune/CNS diseases. It has multi-target collaboration and license agreement with Merck & Co., Inc. Ra Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Cambridge, Massachusetts.

Top 10:

Average Directional Index

Download
Company Close Change(%) Volume Value Signal
NVAX Novavax Inc 11.8 28.1 27,140,609 -19.54 NEUTRAL
STKL Sunopta Inc 2.69 13 767,118 12.17 NEUTRAL
ECPG Encore Capital 34.61 12 1,185,057 23.67 NEUTRAL
NSTG Nanostring Tech 35.86 11.2 1,613,550 -15.89 NEUTRAL
STAA Staar Surgical 31.05 8 1,662,302 21.48 NEUTRAL
KPTI Karyopharm Therapeutics 15.38 7 1,860,063 -18.87 NEUTRAL
CRIS Curis Inc 1.23 7 256,944 12.06 NEUTRAL
DLTH Duluth Holdings 7.39 5.1 226,062 16.01 NEUTRAL
PME Pingtan Marine 1.26 5 12,660 13.8 NEUTRAL
ORBC Orbcomm 3.44 4.2 2,627,367 10.64 NEUTRAL